Project Grant R01CA298812
Award Date 9/15/25
Completion Date 8/31/30
Dollars Obligated $816K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14263, USA
Similar Awards
- This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $885,824 aims to assess consumer response to smokeless tobacco modified risk marketing orders. The research activities will explore 1) consumers' exposure and reactions to authorized smokeless tobacco modified risk tobacco product (MRTP) claims, and 2) whether the MRTP claims influence smokeless tobacco demand and sensory evaluations. The project will be conducted...
- This Project Grant award, valued at $2,353,743.00 and funded by the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research to examine the prevalence and effects of "natural" descriptors and imagery on cigar packaging. The project, led by Rutgers, The State University of New Jersey, aims to 1) analyze Nielsen cigar sales data and physical cigar packs to determine the use of...
- The federal Project Grant award titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit" is funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $663,554.00 with an award date of August 18, 2025 and an ultimate completion date of July 31, 2030. The grant supports research to explore the use of harm reduction product sampling, such as e-cigarettes, heated tobacco products, and oral...
- This Project Grant award of $371,822, funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) and awarded on February 1, 2025, aims to advance the science on the impact of cigar package quantity on cigar use behaviors. The research project has two key objectives: 1) Characterize changes in cigar pack size over time and assess its impact on sales, consumption, and patterns of use using secondary data sources; and 2) Examine how pack size, price, and flavor...
- The Project Grant award of $431,750 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multi-method investigation of premium cigar use and marketing. The research aims to inform the regulation of cigar products, as premium cigars have experienced a resurgence in recent years but lack evidence on their public health impact and patterns of use, especially among young people. The project, to be conducted by Rutgers, The...
- This $515,632 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to prepare the U.S. and states for potential new cigarette product standards that could significantly increase smoking cessation rates. The research team at the University of Minnesota will provide state-specific estimates of the number of people who smoke (PWS) that will quit smoking in response to a menthol ban and nicotine reduction standard, as well as the...
- This Project Grant award of $226,504 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to understand tobacco use trajectories and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities. The study aims to examine disparities in the use of diverse tobacco products, as well as the underlying mechanisms such as marketing exposure and product perceptions, within these populations. The research...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 (Trans-NIH Research Support) is supporting a $675,599 study titled "Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale". The primary awardee is Rutgers, The State University of New Jersey, who will collaborate with Columbia University on the project. The study aims to: 1) characterize the implementation and reach of...
- This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
- This federal Project Grant award from the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $370,000.00 to Marshall University Research Corporation (MURC) to determine the impact of synthetic coolants on nicotine's abuse liability and initiation-related behaviors. The research aims to address a critical knowledge gap in understanding the effects of synthetic coolants used in vaping products, as...